Spire Healthcare Group plc
15 May 2024
Notification of Transactions of Persons Discharging Managerial
Responsibilities
This notification is made in
accordance with DTR 3.1.4R (1) (a) of the Disclosure and
Transparency Rules.
Grant of Long Term Incentive Plan
(LTIP) awards
The Company announces that, on 15
May 2024, a performance share award over 320,675 shares was granted
over the Company's ordinary shares in the form of nil cost options,
under the rules of the Company's LTIP, to Harbant Samra following
his appointment as Chief Financial Officer and an Executive
Director of the Company on 9 May 2024.
The number of shares awarded
represents 200% of Harbant Samra's base salary. It is the maximum
number which may vest under the LTIP Award following the end of the
performance period (31 December 2026). The shareholder-approved
Remuneration Policy permits awards of up to 200% of base salary for
Executive Directors.
The actual number of shares which
vest will depend on the extent to which the relevant performance
conditions have been satisfied.
The performance conditions
applicable to the LTIP Awards will be based as follows:
·
20% on relative total shareholder return (TSR)
performance;
·
35% on ROCE performance;
·
15% on EBITDA Margin performance; and
·
30% on two Operational Excellence
measures.
Further details of these performance
conditions are disclosed in the 2023 Annual Report and
Accounts.
The share price used to determine
the number of shares under the LTIP Award was 237.0 pence being the
average of the mid-market closing share price over the five trading
days ending on 13 March 2024 being the price used to grant awards
to other executives as previously announced.
The transaction place is
London.
Notes:
1) For Harbant Samra the
2024 LTIP awards described above will also be subject to a further
two-year holding period following the vesting date.
2) The actual number of
shares which vest under the LTIP awards will depend on the extent
to which the relevant performance conditions are satisfied in due
course.
3) Harbant Samra holds 34,884 ordinary shares in the
Company.
Name of contact and telephone number
for queries:
Philip Davies
Head of Secretariat
Spire Healthcare Group
plc
Tel:
07803 508348
Notification and public disclosure
of transaction by persons discharging managerial responsibility and
persons closely associated with them
|
1
|
Details of the person discharging managerial
responsibilities/person closely associated
|
|
a)
|
Name
|
Harbant Samra
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Chief Financial
Officer/PDMR
|
|
b)
|
Initial notification
/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Spire Healthcare Group
plc
|
|
b)
|
LEI
|
213800IBJPW3SE2RA350
|
|
4
|
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii) each
date; and (iv) each place where transactions have been
conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Ordinary shares of 1 pence
each
GB00BNLPYF73
|
|
b)
|
Nature of the transaction
|
Grant of performance share awards
under the Company's Long Term Incentive Plan
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
Nil
|
320,675
|
|
|
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
As above
|
|
e)
|
Date of the transaction
|
2024-05-15
|
|
f)
|
Place of the transaction
|
XLON
|